系统性硬化症中的抗磷脂抗体：双重氧化打击？ - Suppr

Suppr

超能文献

Antiphospholipid antibodies in systemic sclerosis: a double oxidative hit?

作者信息

Ames Paul R J

出版信息

Clin Rheumatol. 2009 Aug;28(8):881-2. doi: 10.1007/s10067-009-1210-3. Epub 2009 Jun 10.

DOI:10.1007/s10067-009-1210-3

PMID:19513779

Abstract

摘要

相似文献

Antiphospholipid antibodies in systemic sclerosis: a double oxidative hit?

Clin Rheumatol. 2009 Aug;28(8):881-2. doi: 10.1007/s10067-009-1210-3. Epub 2009 Jun 10.

Antiphospholipid antibodies and kidney involvement in patients with systemic sclerosis.

Clin Rheumatol. 2009 Aug;28(8):955-9. doi: 10.1007/s10067-009-1188-x. Epub 2009 May 13.

Clinical relevance of antiphospholipid antibodies in systemic sclerosis: A systematic review and meta-analysis.

Semin Arthritis Rheum. 2017 Apr;46(5):615-624. doi: 10.1016/j.semarthrit.2016.10.004. Epub 2016 Oct 13.

Emerging potentials for an antioxidant therapy as a new approach to the treatment of systemic sclerosis.

Toxicology. 2000 Nov 30;155(1-3):1-15. doi: 10.1016/s0300-483x(00)00272-9.

Antiphospholipid antibodies and disturbances of phospholipid dependent coagulation tests in patients with systemic sclerosis and severe peripheral ischaemia.

Thromb Res. 1996 Mar 15;81(6):693-5. doi: 10.1016/0049-3848(96)00047-3.

Antioxidant susceptibility of pathogenic pathways in subjects with antiphospholipid antibodies: a pilot study.

Lupus. 2000;9(9):688-95. doi: 10.1191/096120300677692516.

[Treatments for dyslipidemia associated with kidney disease].

Nihon Rinsho. 2001 Mar;59 Suppl 3:748-52.

The emerging problem of oxidative stress and the role of antioxidants in systemic sclerosis.

Clin Exp Rheumatol. 2001 Jan-Feb;19(1):4-8.

Reversal of vascular and renal crises of scleroderma by oral angiotensin-converting-enzyme blockade.

N Engl J Med. 1979 Jun 21;300(25):1417-9. doi: 10.1056/NEJM197906213002505.

[Antiphospholipid antibodies and systemic scleroderma. Apropos of a case with review of the literature].

Tunis Med. 1995 Feb;73(2):149-52.

引用本文的文献

Digital gangrene in systemic sclerosis patients: not only due to the microvascular disease.

Clin Rheumatol. 2024 Mar;43(3):1083-1092. doi: 10.1007/s10067-024-06886-8. Epub 2024 Feb 2.

Influence of antiphospholipid antibody positivity on glomerular filtration rate markers in a group of systemic sclerosis patients - a 24-month observation.

Cent Eur J Immunol. 2017;42(2):161-166. doi: 10.5114/ceji.2017.69358. Epub 2017 Aug 8.

Antiphospholipid antibodies and systemic scleroderma.

Turk J Haematol. 2013 Mar;30(1):32-6. doi: 10.4274/tjh.2012.0059. Epub 2013 Mar 5.

本文引用的文献

Antiphospholipid antibodies and kidney involvement in patients with systemic sclerosis.

Clin Rheumatol. 2009 Aug;28(8):955-9. doi: 10.1007/s10067-009-1188-x. Epub 2009 May 13.

Anticardiolipin and anti-beta2 glycoprotein I antibodies and lupus-like anticoagulant: prevalence and significance in systemic sclerosis.

Br J Dermatol. 2008 Jan;158(1):141-4. doi: 10.1111/j.1365-2133.2007.08309.x. Epub 2007 Nov 19.

A novel overlap syndrome: systemic sclerosis associated with antiphospholipid syndrome--a case series.

Ann N Y Acad Sci. 2007 Jun;1108:497-504. doi: 10.1196/annals.1422.053.

8-Isoprostane-induced endothelin-1 production by infant rat pulmonary artery smooth muscle cells is mediated by Rho-kinase.

Free Radic Biol Med. 2006 Sep 15;41(6):942-9. doi: 10.1016/j.freeradbiomed.2006.05.035. Epub 2006 Jun 17.

Serum levels of 8-isoprostane, a marker of oxidative stress, are elevated in patients with systemic sclerosis.

Rheumatology (Oxford). 2006 Jul;45(7):815-8. doi: 10.1093/rheumatology/kel012. Epub 2006 Jan 31.

International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS).

J Thromb Haemost. 2006 Feb;4(2):295-306. doi: 10.1111/j.1538-7836.2006.01753.x.

Antiphospholipid antibodies in patients with scleroderma: prevalence and clinical significance.

Ann Rheum Dis. 2005 Dec;64(12):1795-6. doi: 10.1136/ard.2005.038430.

Levels of F2-isoprostanes in systemic sclerosis: correlation with clinical features.

Rheumatology (Oxford). 2006 Mar;45(3):314-20. doi: 10.1093/rheumatology/kei151. Epub 2005 Oct 11.

Autoantibodies against phosphatidylserine-prothrombin complex in patients with systemic sclerosis.

Ann Rheum Dis. 2004 Nov;63(11):1514-7. doi: 10.1136/ard.2003.016659.

Endothelin and endothelin receptor antagonists in systemic rheumatic disease.

Arthritis Rheum. 2003 May;48(5):1190-9. doi: 10.1002/art.10895.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验